» Articles » PMID: 25296306

The Mechanism of Phagocytosis: Two Stages of Engulfment

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2014 Oct 9
PMID 25296306
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Despite being of vital importance to the immune system, the mechanism by which cells engulf relatively large solid particles during phagocytosis is still poorly understood. From movies of neutrophil phagocytosis of polystyrene beads, we measure the fractional engulfment as a function of time and demonstrate that phagocytosis occurs in two distinct stages. During the first stage, engulfment is relatively slow and progressively slows down as phagocytosis proceeds. However, at approximately half-engulfment, the rate of engulfment increases dramatically, with complete engulfment attained soon afterwards. By studying simple mathematical models of phagocytosis, we suggest that the first stage is due to a passive mechanism, determined by receptor diffusion and capture, whereas the second stage is more actively controlled, perhaps with receptors being driven toward the site of engulfment. We then consider a more advanced model that includes signaling and captures both stages of engulfment. This model predicts that there is an optimum ligand density for quick engulfment. Further, we show how this model explains why nonspherical particles engulf quickest when presented tip-first. Our findings suggest that active regulation may be a later evolutionary innovation, allowing fast and robust engulfment even for large particles.

Citing Articles

Biosilicification-mimicking chiral nanostructures for targeted treatment of inflammatory bowel disease.

Xu M, Xin W, Xu J, Wang A, Ma S, Dai D Nat Commun. 2025; 16(1):2551.

PMID: 40089457 DOI: 10.1038/s41467-025-57890-8.


Deciphering neutrophil dynamics: Enhanced phagocytosis of elastic particles and impact on vascular-targeted carrier performance.

Lee J, Guevara M, Akanbi O, Hoff J, Kupor D, Brannon E Sci Adv. 2025; 11(1):eadp1461.

PMID: 39752488 PMC: 11698085. DOI: 10.1126/sciadv.adp1461.


Efferocytosis: The Janus-Faced Gatekeeper of Aging and Tumor Fate.

Liu Z, Li Y, Ren Y, Chen J, Weng S, Zhou Z Aging Cell. 2025; 24(2):e14467.

PMID: 39748782 PMC: 11822654. DOI: 10.1111/acel.14467.


Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.

Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S Front Immunol. 2024; 15:1485222.

PMID: 39660125 PMC: 11628373. DOI: 10.3389/fimmu.2024.1485222.


An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.

Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K Sci Rep. 2024; 14(1):30107.

PMID: 39627312 PMC: 11615046. DOI: 10.1038/s41598-024-79154-z.


References
1.
Hoppe A, Swanson J . Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis. Mol Biol Cell. 2004; 15(8):3509-19. PMC: 491814. DOI: 10.1091/mbc.e03-11-0847. View

2.
Pontes B, Ayala Y, Fonseca A, Romao L, Amaral R, Salgado L . Membrane elastic properties and cell function. PLoS One. 2013; 8(7):e67708. PMC: 3701085. DOI: 10.1371/journal.pone.0067708. View

3.
Joshi T, Butchar J, Tridandapani S . Fcγ Receptor Signaling in Phagocytes. Int J Hematol. 2018; 84(3):210-216. DOI: 10.1532/IJH97.06140. View

4.
Cannon G, Swanson J . The macrophage capacity for phagocytosis. J Cell Sci. 1992; 101 ( Pt 4):907-13. DOI: 10.1242/jcs.101.4.907. View

5.
Lee C, Herant M, Heinrich V . Target-specific mechanics of phagocytosis: protrusive neutrophil response to zymosan differs from the uptake of antibody-tagged pathogens. J Cell Sci. 2011; 124(Pt 7):1106-14. PMC: 3056606. DOI: 10.1242/jcs.078592. View